ATP1A2 expression was significantly lower in breast invasive carcinoma, bladder urothelial carcinoma and colon adenocarcinoma (all p < 0.001) than in the adjacent normal tissues. This evidence concerns the gene ATP1A2 and colon adenocarcinoma.